AVESIS INC
SC 13D/A, 1997-12-18
BUSINESS SERVICES, NEC
Previous: HEALTH MANAGEMENT ASSOCIATES INC, DEF 14A, 1997-12-18
Next: DMI INC /CO/, 10QSB, 1997-12-18



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  Schedule 13D

           Under the Securities Exchange Act of 1934 (Amendment No. 3)

                               AVESIS INCORPORATED
                               -------------------
                                (Name of issuer)

                                  COMMON STOCK
                                  ------------
                         (Title of Class of Securities)

                                    053650107
                                    ---------
                                 (CUSIP Number)

                              Kenneth L. Blum, Jr.
     11460 Cronridge Drive, Suite 120, Owings Mills, MD 21117 (410) 265-6074
     -----------------------------------------------------------------------
                  (Name, Address and Telephone Number of Person
                 Authorized to Receive Notes and Communications)

                                January 27, 1997
                                ----------------
                          (Date of Event which Requires
                            Filing of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-l(b)(3) or (4), check the following box [ ].

Note: Six copies of this statement, including all exhibits, should be filed with
the  Commission.  See Rule  13d-l(a) for other  parties to whom copies are to be
sent.

* The remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).

                        (Continued on following page(s))

                                  Page 1 of 14
<PAGE>
CUSIP No. 053650107                                           Page 2 of 14 Pages
          ---------
<TABLE>
<CAPTION>

- -------------------------------------------------------------------------------------------------------
<S>                            <C>
1                              NAME OF REPORTING PERSONS.
                               I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only)
                                    NATIONAL HEALTH ENTERPRISES, INC.
- -------------------------------------------------------------------------------------------------------
2                              CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
                                                                                             (a)   [X]
                                                                                             (b)   [ ]
- -------------------------------------------------------------------------------------------------------
3                              SEC USE ONLY

- -------------------------------------------------------------------------------------------------------
4                              SOURCE OF FUNDS (See Instructions)
                                    N/A
- -------------------------------------------------------------------------------------------------------
5                              CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
                               ITEMS 2(d) OR 2(e)
                                                                                                   [ ]
- -------------------------------------------------------------------------------------------------------
6                              CITIZENSHIP OR PLACE OF ORGANIZATION
                                    Maryland
- -------------------------------------------------------------------------------------------------------
                         7     SOLE VOTING POWER
     Number of                      -0-
      Shares         ----------------------------------------------------------------------------------
   Beneficially          8     SHARED VOTING POWER
     Owned by
       Each          ----------------------------------------------------------------------------------
     Reporting           9     SOLE DISPOSITIVE POWER
      Person                        -0-
       With          ----------------------------------------------------------------------------------
                        10     SHARED DISPOSITIVE POWER

- -------------------------------------------------------------------------------------------------------
11                             AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                                    -0-
- -------------------------------------------------------------------------------------------------------
12                             CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
                               (See Instructions)
                                                                                                   [ ]
- -------------------------------------------------------------------------------------------------------
13                             PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                                    0.0%
- -------------------------------------------------------------------------------------------------------
14                             TYPE OF REPORTING PERSON
                                    CO
- -------------------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
CUSIP No. 053650107                                           Page 3 of 14 Pages
          ---------
<TABLE>
<CAPTION>

- -------------------------------------------------------------------------------------------------------
<S>                            <C>
1                              NAME OF REPORTING PERSONS.
                               I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only)
                                    KENNETH L. BLUM, JR.
- -------------------------------------------------------------------------------------------------------
2                              CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
                                                                                             (a)   [X]
                                                                                             (b)   [ ]
- -------------------------------------------------------------------------------------------------------
3                              SEC USE ONLY

- -------------------------------------------------------------------------------------------------------
4                              SOURCE OF FUNDS (See Instructions)
                                    N/A
- -------------------------------------------------------------------------------------------------------
5                              CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
                               ITEMS 2(d) OR 2(e)
                                                                                                   [ ]
- -------------------------------------------------------------------------------------------------------
6                              CITIZENSHIP OR PLACE OF ORGANIZATION
                                    UNITED STATES
- -------------------------------------------------------------------------------------------------------
                         7     SOLE VOTING POWER
     Number of                      1,839,750
      Shares         ----------------------------------------------------------------------------------
   Beneficially          8     SHARED VOTING POWER
     Owned by                          50,000
       Each          ----------------------------------------------------------------------------------
     Reporting           9     SOLE DISPOSITIVE POWER
      Person                        1,839,750
       With          ----------------------------------------------------------------------------------
                        10     SHARED DISPOSITIVE POWER
                                       50,000
- -------------------------------------------------------------------------------------------------------
11                             AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
                                    1,889,750
- -------------------------------------------------------------------------------------------------------
12                             CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
                               (See Instructions)
                                                                                                   [ ]
- -------------------------------------------------------------------------------------------------------
13                             PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
                                    31.8%
- -------------------------------------------------------------------------------------------------------
14                             TYPE OF REPORTING PERSON
                                    IN
- -------------------------------------------------------------------------------------------------------
</TABLE>
<PAGE>
Item 1.           Security and Issuer.

                  This Statement relates to Common Stock of Avesis  Incorporated
(the "Issuer"). The principal executive offices of the Issuer are located at 100
West Clarendon Avenue, Suite 2300, Phoenix, Arizona 85013.

Item 2.           Identity and Background.

                  (a)  This   statement  is  being  filed  by  National   Health
Enterprises, Inc., a Maryland corporation ("NHE") and Kenneth L. Blum, Jr.

                  (b) The address for NHE and Mr. Blum is 11460 Cronridge Drive,
Suite 120, Owings Mills, Maryland 21117.

                  (c) The principal business of NHE is providing  management and
marketing  services to  companies  engaged in the  business of offering  vision,
dental hearing and chiropractic benefit programs.  Mr. Blum is the president and
sole owner of NHE;  president of Rent-A-Wreck  of America,  Inc., a used vehicle
rental system franchisor;  president of American Business  Information  Systems,
Inc., a high-volume  laser printing company and National  Computer  Services,  a
computer service bureau and division of American Business  Information  Systems,
Inc.; and a consultant to United Healthcare, Inc.

                  (d) During the last five years,  the filing  persons  have not
been convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors).

                  (e) During the last five years,  the filing  persons  have not
been a party to a civil  proceeding  of a  judicial  or  administrative  body of
competent jurisdiction and are not subject to a judgment,  decree or final order
enjoining future violations of, or prohibiting or mandating  activities  subject
to,  federal or state  securities  laws or finding any violation with respect to
such laws.

                  (f) NHE is a Maryland  corporation.  Mr.  Blum is a citizen of
the United States.

Item 3.           Source and Amount of Funds or Other Consideration.

                  The funds used to purchase  the 50,000  shares of Common Stock
as to which Mr. Blum has shared voting and dispositive  power were obtained from
Mr. Blum's parents.  The remaining shares reported as beneficially  owned herein
underlie   unexercised  stock  purchase  options.  No  funds  were  expended  in
connection with the acquisition or disposition of the options reported herein.

                                  Page 4 of 14
<PAGE>
Item 4.           Purpose of Transaction.

                  The options  discussed in Item 5 were acquired for investment.
The options were originally issued by the Issuer to National Health Enterprises,
Inc.  ("NHE") in  connection  with the retention by the Issuer of NHE to perform
management  services  for the Issuer  pursuant  to a  management  contract  (the
"Management Agreement").  To that extent, the acquisition of the options relates
to a change in the management of the Issuer.  NHE transferred all Issuer options
to Issuer's management as incentive.  Such transfers are automatically rescinded
when a transferee ceases to perform  substantial  services for the Issuer.  Such
automatic  rescission and  subsequent  transfer of options was the nature of the
transaction  requiring  the filing of the amended  Schedule  13D.  See Item 5(c)
below.

                  All of the Issuer's  shares held by Mr. Blum were acquired and
are held for investment  purposes only.  Except as described  above, NHE and Mr.
Blum have no present plan or proposal  that relates to or would result in any of
the actions  described  in clauses  (a)  through (j) of Item 4 of Schedule  13D,
although they may from time to time in the future acquire  additional  shares of
Common Stock or securities  convertible  into Common Stock. At present,  NHE and
Mr.  Blum  contemplate  that  such  additional  shares,  if any,  would  also be
purchased for investment purposes only.

Item 5.           Interest In Securities of the Issuer.

                  (a) The aggregate number and percentage of Issuer Common Stock
beneficially  owned by NHE is 0 and 0.0%,  respectively.  Mr. Blum  beneficially
owns an aggregate of 1,839,750  shares of the Company's Common Stock pursuant to
options,  and holds 50,000 shares of Common Stock with his spouse,  representing
31.8% of the class.

                  (b) See Items 7 through 10 on the Cover Pages of this Schedule
13D.

                  (c) NHE effected the following transaction since 60 days prior
to the date of the event which requires filing of this statement:

                           (i) A total of 400,000  fully vested  stock  purchase
options,  which were  originally  granted to NHE from the Issuer,  automatically
reverted  back to NHE on January 27, 1997 pursuant to the terms of the agreement
by which NHE transferred the options to Issuer's previous president. The options
were originally granted at an exercise price of $0.48 per share.

                           (ii) NHE  transferred  an  aggregate  of the  400,000
fully vested  stock  purchase  options  mentioned in Item 5(c)(i) on January 27,
1997 to consultants and employees of the Company.  The options were  transferred
at an exercise price of $0.48 per share,  subject to the terms and conditions of
the originally granted shares to NHE by the Issuer.

                  (d) Mr. Blum shares voting and dispositive  power as to 50,000
shares of the Company's Common Stock with his spouse.

                                  Page 5 of 14
<PAGE>
                  (e) NHE  ceased to be the  beneficial  owner of more than five
percent of the Common Stock of the Company as of January 27, 1997.

Item 6.           Contracts, Arrangements,  Understandings or Relationships With
                  Respect to Securities of the Issuer.

                  The shares reported herein are beneficially owned by virtue of
fully vested stock  purchase  options.  Except as set forth above,  there are no
other contracts, arrangements, understandings, or relationships among NHE and/or
Mr. Blum and any other person with respect to any securities of the Issuer.

Item 7.           Material to be Filed as Exhibits.

                  1.       Management Agreement dated March 18, 1993 between the
                           Issuer and NHE.*

                  2.       Stock  Option  Grant  to NHE  dated  March  18,  1993
                           relating  to options for the  purchase  of  4,400,000
                           shares of the Issuer's Common Stock.*

                  3.       Subordinated  Promissory Note dated March 18, 1993 in
                           the  amount of  $80,000  payable by Issuer to Mr. and
                           Mrs. Blum.*

                  4.       Registration  Rights  Agreement  dated March 18, 1993
                           among NHE, Mr. Blum, and Alan S. Cohn.*

                  5.       Marketing  Agreement dated March 18, 1993 between the
                           Issuer and NHE.*

                  6.       Option Transfer Document dated March 31, 1993**

                  7.       Certification  Regarding Joint Filing of Schedule 13D
                           Pursuant to Rule 13d-1(f).

                  8.       Option  transfer  letter from NHE to Neal A.  Kempler
                           effective January 27, 1997.

                  9.       Option  transfer  letter  from NHE to Michael  Reamer
                           effective January 27, 1997.

                  10.      Option  transfer  letter  from NHE to Joe E.  Johnson
                           effective January 27, 1997.

                  *        Incorporated  by  reference  from  Schedule 13D dated
                           March 18, 1993 filed by NHE and Mr. and Mrs.  Kenneth
                           L. Blum, Jr.

                  **       Incorporated  by reference  from  Amendment  No. 2 to
                           Schedule  13D dated  December  5,  1994  filed by Mr.
                           Frank C. Cappadora.

                                  Page 6 of 14
<PAGE>
                                    SIGNATURE

                  After reasonable  inquiry and to the best of our knowledge and
belief,  we certify that the  information  set forth in this  statement is true,
complete and correct.


     12/17 , 1997
- -----------------

                                               /s/ Kenneth L. Blum, Jr.
                                               ---------------------------------
                                                   KENNETH L. BLUM, JR.


                                               NATIONAL HEALTH ENTERPRISES, INC.


                                               By; /s/ Kenneth L. Blum, Jr.
                                                  ------------------------------
                                                       KENNETH L. BLUM, JR.
                                                       PRESIDENT

                                  Page 7 of 14
<PAGE>
                                    EXHIBIT 7

                     CERTIFICATION REGARDING JOINT FILING OF
                     ---------------------------------------
                     SCHEDULE 13D PURSUANT TO RULE 13d-1(f)
                     --------------------------------------
                    OF THE SECURITIES AND EXCHANGE COMMISSION
                    -----------------------------------------


                  National Health Enterprises,  Inc., a Maryland corporation and
Kenneth L.  Blum,  Jr. do hereby  certify  that the  Schedule  13D to which this
certification  is attached as Exhibit 7 is being filed with the  Securities  and
Exchange Commission on behalf of each of the undersigned.


Dated:      12/17 , 1997                      NATIONAL HEALTH ENTERPRISES, INC.
       -----------------

                                              By: /s/ Kenneth L. Blum, Jr.
                                                 ------------------------------
                                                      KENNETH L. BLUM, JR.
                                                      PRESIDENT



                                              /s/ Kenneth L. Blum, Jr.
                                              ---------------------------------
                                                  KENNETH L. BLUM, JR.

                                  Page 8 of 14
<PAGE>
                                    EXHIBIT 8


                        NATIONAL HEALTH ENTERPRISES INC.
                              11460 Cronridge Drive
                                    Suite 120
                          Owings Mills, Maryland 21117



Neal A. Kempler
c/o Avesis Incorporated
100 West Clarendon Avenue
Suite #2300
Phoenix, Arizona  85013

                  re: Option Transfer

Dear Neal:

         Pursuant to a Stock Option Grant (the "Grant  Letter")  dated March 18,
1993, National Health Enterprises Inc., a Maryland  corporation ("NHE") acquired
options (the  "Options") to purchase up to 4,400,000  shares of the Common Stock
of Avesis  Incorporated,  a Delaware  corporation (the "Company") subject to the
terms and conditions  set forth in the Grant Letter.  A copy of the Grant Letter
is attached hereto.

         Pursuant to Section 4 of the Grant  Letter,  and in  consideration  for
services  performed and to be performed on behalf of NHE in connection  with the
Management  Agreement  dated March 18, 1993  between  NHE and the  Company,  NHE
hereby transfers to you Options (the "Transferred  Options") for the purchase of
200,000  shares of the Company's  Common Stock.  The terms and conditions of the
Transferred  Options shall be identical to the terms and conditions set forth In
the Letter of Grant except as follows:

                  1. The  options  are  fully  vested  as a result  the Board of
Directors  resolution  included in the minutes of the December 5, 1994  meeting,
and are transferred as such to the optionee.

                  2. The  limited  transfer  right set forth in Section 4 of the
Letter of Grant is not available to you.

                  3. Any rights you may have under the Transferred Options shall
terminate,  and the  Transferred  Options shall once again be exercisable (if at
all)  solely by NHE,  within 90 days  after  you  cease  performing  substantial
services  for or on behalf of the Company,  provided  that your rights under the
Transferred Options shall terminate immediately if the cessation is for

                                  Page 9 of 14
<PAGE>
cause,  and  further  provided  that this clause  shall not extend the  exercise
period set forth in the Letter of Grant.

                  4. You  acknowledge  that the Company has advised you that all
transactions  associated with the Transferred  Options have complex and material
tax  consequences,  the  effect of which  can vary  according  to your  personal
circumstances,  and that the Company has advised you to obtain  independent  tax
advice as to all matters relating to the Transferred Options.

                  5.  You  acknowledge  and  agree  to  all  of  the  terms  and
conditions of the attached  Letter of Grant,  as Modified by the above terms and
conditions.

                  6. This Transfer shall be effective as of January 27, 1997.

         Please indicate your  acknowledgment and acceptance of the foregoing by
executing this letter in the space indicated below.


                                        Sincerely,

                                        NATIONAL HEALTH ENTERPRISES, INC.


                                        By:  /s/ Kenneth L. Blum, Jr.
                                             ----------------------------
                                             Kenneth L. Blum, Jr., President

Acknowledged and accepted:


/s/ Neal A. Kempler
- -------------------------
Neal A. Kempler

                                  Page 10 of 14
<PAGE>
                                    EXHIBIT 9


                        NATIONAL HEALTH ENTERPRISES INC.
                              11460 Cronridge Drive
                                    Suite 120
                          Owings Mills, Maryland 21117



Michael Reamer
c/o Avesis Incorporated
100 West Clarendon Avenue
Suite #2300
Phoenix, Arizona  85013

                  re: Option Transfer

Dear Michael:

         Pursuant to a Stock Option Grant (the "Grant  Letter")  dated March 18,
1993, National Health Enterprises Inc., a Maryland  corporation ("NHE") acquired
options (the  "Options") to purchase up to 4,400,000  shares of the Common Stock
of Avesis  Incorporated,  a Delaware  corporation (the "Company") subject to the
terms and conditions set forth in the Grant Letter. A copy of the  Grant  Letter
is attached hereto.

         Pursuant to Section 4 of the Grant  Letter,  and in  consideration  for
services  performed and to be performed on behalf of NHE in connection  with the
Management  Agreement  dated March 18, 1993  between  NHE and the  Company,  NHE
hereby transfers to you Options (the "Transferred  Options") for the purchase of
100,000  shares of the Company's  Common Stock.  The terms and conditions of the
Transferred  Options shall be identical to the terms and conditions set forth In
the Letter of Grant except as follows:

                  1. The  options  are  fully  vested  as a result  the Board of
Directors  resolution  included in the minutes of the December 5, 1994  meeting,
and are transferred as such to the optionee.

                  2. The  limited  transfer  right set forth in Section 4 of the
Letter of Grant is not available to you.

                  3. Any rights you may have under the Transferred Options shall
terminate,  and the  Transferred  Options shall once again be exercisable (if at
all)  solely by NHE,  within 90 days  after  you  cease  performing  substantial
services  for or on behalf of the Company,  provided  that your rights under the
Transferred Options shall terminate immediately if the cessation is for

                                  Page 11 of 14
<PAGE>
cause,  and  further  provided  that this clause  shall not extend the  exercise
period set forth in the Letter of Grant.

                  4. You  acknowledge  that the Company has advised you that all
transactions  associated with the Transferred  Options have complex and material
tax  consequences,  the  effect of which  can vary  according  to your  personal
circumstances,  and that the Company has advised you to obtain  independent  tax
advice as to all matters relating to the Transferred Options.

                  5.  You  acknowledge  and  agree  to  all  of  the  terms  and
conditions of the attached  Letter of Grant,  as Modified by the above terms and
conditions.

                  6. This Transfer shall be effective as of January 27, 1997.

         Please indicate your  acknowledgment and acceptance of the foregoing by
executing this letter in the space indicated below.


                                        Sincerely,

                                        NATIONAL HEALTH ENTERPRISES, INC.


                                        By:  /s/ Kenneth L. Blum Jr.
                                             ------------------------------
                                             Kenneth L. Blum, Jr., President

Acknowledged and accepted:


/s/ Michael Reamer
- ---------------------
Michael Reamer

                                  Page 12 of 14
<PAGE>
                                   EXHIBIT 10


                        NATIONAL HEALTH ENTERPRISES INC.
                              11460 Cronridge Drive
                                    Suite 120
                          Owings Mills, Maryland 21117



Joe E. Johnson
c/o Avesis Incorporated
100 West Clarendon Avenue
Suite #2300
Phoenix, Arizona  85013

                  re: Option Transfer

Dear Joe:

         Pursuant to a Stock Option Grant (the "Grant  Letter")  dated March 18,
1993, National Health Enterprises Inc., a Maryland  corporation ("NHE") acquired
options (the  "Options") to purchase up to 4,400,000  shares of the Common Stock
of Avesis  Incorporated,  a Delaware  corporation (the "Company") subject to the
terms and conditions  set forth in the Grant Letter.  A copy of the Grant Letter
is attached hereto.

         Pursuant to Section 4 of the Grant  Letter,  and in  consideration  for
services  performed and to be performed on behalf of NHE in connection  with the
Management  Agreement  dated March 18, 1993  between  NHE and the  Company,  NHE
hereby transfers to you Options (the "Transferred  Options") for the purchase of
100,000  shares of the Company's  Common Stock.  The terms and conditions of the
Transferred  Options shall be identical to the terms and conditions set forth In
the Letter of Grant except as follows:

                  1. The  options  are  fully  vested  as a result  the Board of
Directors  resolution  included in the minutes of the December 5, 1994  meeting,
and are transferred as such to the optionee.

                  2. The  limited  transfer  right set forth in Section 4 of the
Letter of Grant is not available to you.

                  3. Any rights you may have under the Transferred Options shall
terminate,  and the  Transferred  Options shall once again be exercisable (if at
all)  solely by NHE,  within 90 days  after  you  cease  performing  substantial
services  for or on behalf of the Company,  provided  that your rights under the
Transferred  Options shall terminate  immediately if the cessation is for cause,
and

                                  Page 13 of 14
<PAGE>
further provided that this clause shall not extend the exercise period set forth
in the Letter of Grant.

                  4. You  acknowledge  that the Company has advised you that all
transactions  associated with the Transferred  Options have complex and material
tax  consequences,  the  effect of which  can vary  according  to your  personal
circumstances,  and that the Company has advised you to obtain  independent  tax
advice as to all matters relating to the Transferred Options.

                  5.  You  acknowledge  and  agree  to  all  of  the  terms  and
conditions of the attached  Letter of Grant,  as Modified by the above terms and
conditions.

                  6. This Transfer shall be effective as of January 27, 1997.

         Please indicate your  acknowledgment and acceptance of the foregoing by
executing this letter in the space indicated below.


                                        Sincerely,

                                        NATIONAL HEALTH ENTERPRISES, INC.


                                        By:  /s/ Kenneth L. Blum, Jr.
                                             -----------------------------
                                             Kenneth L. Blum, Jr., President

Acknowledged and accepted:


/s/ Joe E. Johnson
- ----------------------
Joe E. Johnson

                                  Page 14 of 14


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission